RUNX1 and acute lymphoblastic leukemia: ETV6-RUNX1 and hyperdiploid ALL were highly sensitive to the four drugs commonly used in remission induction (PVDL), recapitulating the known chemotherapy-responsive nature of these subtypes9,10.